AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANTX AN2 Therapeutics, Inc.

盘前交易 04-26 06:39:21 EDT

2.28

-0.12

-5.00%

最高2.40	最低2.28	成交量17.89万
今开2.39	昨收2.40	日振幅5.00%
总市值6,788万	流通市值2,366万	总股本2,977万
成交额41.63万	换手率1.72%	流通股本1,038万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":2.28,"timestamp":1714075200000,"preClose":2.4,"halted":0,"volume":178937,"delay":0,"floatShares":10378074,"shares":29770375,"eps":-2.742868,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.12,"latestTime":"04-26 06:39:21 EDT","open":2.39,"high":2.4,"low":2.28,"amount":416260.01579689997,"amplitude":0.05,"askPrice":2.67,"askSize":100,"bidPrice":2.28,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.742868,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714138200000},"adr":0,"listingDate":1648180800000,"adjPreClose":2.28,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.28,"latestTime":"18:42 EDT","volume":741,"amount":1722.89,"timestamp":1714084948932},"volumeRatio":1.8220414069822928},"requestUrl":"/m/hq/s/ANTX/tweets","defaultTab":"tweets","newsList":[{"id":"2427000946","title":"An2 Therapeutics, Inc.盘中异动 早盘急速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427000946","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427000946?lang=zh_cn&edition=full","pubTime":"2024-04-15 23:16","pubTimestamp":1713194217,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日23时16分，An2 Therapeutics, Inc.股票出现异动，股价急速下跌5.11%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，安皮奥制药、Soligenix, Inc.、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1376.41%、1101.37%、787.28%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、90.57%、80.04%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152316577a52def7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152316577a52def7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420872113","title":"An2 Therapeutics, Inc.盘中异动 早盘快速上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420872113","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420872113?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:08","pubTimestamp":1710947293,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日23时08分，An2 Therapeutics, Inc.股票出现波动，股价大幅拉升5.54%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320230813791bc1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320230813791bc1e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417760416","title":"An2 Therapeutics, Inc.盘中异动 快速拉升5.23%报3.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417760416","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417760416?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:49","pubTimestamp":1709822975,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日22时49分，An2 Therapeutics, Inc.股票出现异动，股价快速拉升5.23%。截至发稿，该股报3.02美元/股，成交量4.8106万股，换手率0.16%，振幅4.53%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.47%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072249367a4a802b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072249367a4a802b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415253075","title":"An2 Therapeutics, Inc.盘中异动 大幅拉升5.63%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415253075","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415253075?lang=zh_cn&edition=full","pubTime":"2024-02-29 23:10","pubTimestamp":1709219411,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日23时10分，An2 Therapeutics, Inc.股票出现波动，股价急速拉升5.63%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.22%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022923101287e74ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022923101287e74ead&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414387205","title":"An2 Therapeutics Inc盘中异动 股价大跌5.11%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414387205","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414387205?lang=zh_cn&edition=full","pubTime":"2024-02-28 04:33","pubTimestamp":1709066022,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日04时33分，An2 Therapeutics Inc股票出现异动，股价快速下跌5.11%。截至发稿，该股报2.97美元/股，成交量64.75万股，换手率2.18%，振幅5.88%。An2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.39%。An2 Therapeutics Inc公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228043342791526d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228043342791526d5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414468836","title":"An2 Therapeutics Inc盘中异动 股价大涨5.18%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414468836","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414468836?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:22","pubTimestamp":1708960956,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时22分，An2 Therapeutics Inc股票出现异动，股价大幅拉升5.18%。截至发稿，该股报3.25美元/股，成交量9.4782万股，换手率0.32%，振幅5.18%。An2 Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Zyversa Therapeutics Inc、Calidi Biotherapeutics Inc、Krystal Biotech Inc涨幅较大，Zyversa Therapeutics Inc、Lixte Biotechnology Holdings  Inc、Ocean Biomedical Inc较为活跃，换手率分别为1343.91%、61.68%、57.65%，振幅较大的相关个股有Zyversa Therapeutics Inc、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ocean Biomedical Inc，振幅分别为144.82%、62.88%、52.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262322377914b516&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262322377914b516&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411338359","title":"美国研究综述-An2 Therapeutics、Par Technology、Trimble","url":"https://stock-news.laohu8.com/highlight/detail?id=2411338359","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411338359?lang=zh_cn&edition=full","pubTime":"2024-02-13 15:10","pubTimestamp":1707808204,"startTime":"0","endTime":"0","summary":"    路透社2月13日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 An2 Therapeutics、Par Technology 和 Trimble。公司要闻 * An2 Therapeutics Inc   ：Leerink Partners将其评级从 \"跑赢大盘 \"下调至 \"市场表现\"。* Par Technology Corp   ：Benchmark给予其 \"持有 \"评级 * Trimble Inc   ：Piper Sandler 将其评级从 \"中性 \"上调至 \"增持\"。* Cymabay Therapeutics Inc   ：B. Riley 将目标价从 29 美元上调至 32.5 美元 * Cymabay Therapeutics Inc   ：Jonestrading将其目标价从 \"买入 \"下调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2410405668","title":"嗡嗡声--美国股票走势-Diamondback、Rivian Automotive、BioXcel Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2410405668","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410405668?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:23","pubTimestamp":1707747784,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月12日 - 继前一周强劲收盘后，周一美国股指期货表现低迷，市场关注一系列经济数据，这些数据可能会消除降息前景的一些不确定性。美东时间9:01，道指电子盘  下跌0.10%，报38,710点。标准普尔500指数小型股  下跌0.03%，报5,042.25点；纳斯达克100指数小型股  下跌0.05%，报18,029.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2388142902","title":"An2 Therapeutics Inc盘中异动 急速上涨6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2388142902","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2388142902?lang=zh_cn&edition=full","pubTime":"2023-12-01 00:58","pubTimestamp":1701363483,"startTime":"0","endTime":"0","summary":"北京时间2023年12月01日00时58分，An2 Therapeutics Inc股票出现异动，股价大幅拉升6.86%。截至发稿，该股报17.45美元/股，成交量5236股，换手率0.02%，振幅6.43%。An2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Soligenix Inc、Immunogen Inc、Biocardia Inc C/Wts 06/08/2024涨幅较大，Aditxt Inc、Clearmind Medicine Inc、Altamira Therapeutics Ltd较为活跃，换手率分别为1436.41%、860.56%、650.11%，振幅较大的相关个股有Soligenix Inc、Neubase Therapeutics Inc、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为336.88%、110.25%、98.95%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312010058048309d918&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312010058048309d918&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2385661576","title":"An2 Therapeutics Inc盘中异动 大幅跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2385661576","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2385661576?lang=zh_cn&edition=full","pubTime":"2023-11-23 01:37","pubTimestamp":1700674638,"startTime":"0","endTime":"0","summary":"北京时间2023年11月23日01时37分，An2 Therapeutics Inc股票出现异动，股价大幅下挫5.01%。截至发稿，该股报16.10美元/股，成交量6.781万股，换手率0.23%，振幅5.04%。An2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Clene Inc C/Wts 30/12/2025 、Impel Pharmaceuticals Inc涨幅较大，Paxmedica Inc、Scisparc Ltd、Altamira Therapeutics Ltd较为活跃，换手率分别为2730.36%、2188.62%、83.96%，振幅较大的相关个股有Impel Pharmaceuticals Inc、Clene Inc C/Wts 30/12/2025 、Alaunos Therapeutics Inc，振幅分别为87.37%、57.91%、50.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231123013718839f21e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231123013718839f21e0&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.an2therapeutics.com","stockEarnings":[{"period":"1week","weight":-0.042},{"period":"1month","weight":-0.2692},{"period":"3month","weight":-0.8831},{"period":"6month","weight":-0.8431},{"period":"1year","weight":-0.7213},{"period":"ytd","weight":-0.8887}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AN2 Therapeutics, Inc.于2017年2月在特拉华州注册成立。他们是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的治疗方法。他们的核心技术方法基于将硼化学用于他们的药物研发计划。他们正在开发用于治疗NTM肺病的口服epetraborole，这是一种罕见的慢性进行性传染病，由称为分枝杆菌的细菌引起，可导致不可逆的肺损伤并可能致命。","exchange":"NASDAQ","name":"AN2 Therapeutics, Inc.","nameEN":"AN2 Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AN2 Therapeutics, Inc.(ANTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AN2 Therapeutics, Inc.,ANTX,AN2 Therapeutics, Inc.股票,AN2 Therapeutics, Inc.股票老虎,AN2 Therapeutics, Inc.股票老虎国际,AN2 Therapeutics, Inc.行情,AN2 Therapeutics, Inc.股票行情,AN2 Therapeutics, Inc.股价,AN2 Therapeutics, Inc.股市,AN2 Therapeutics, Inc.股票价格,AN2 Therapeutics, Inc.股票交易,AN2 Therapeutics, Inc.股票购买,AN2 Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AN2 Therapeutics, Inc.(ANTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}